Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Solutions for Trial Design Challenges in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications How To Prevent Failure in Rare Disease Trials? Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Solutions for Trial Design Challenges in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications How To Prevent Failure in Rare Disease Trials? Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials